Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Chemotherapy in recurrent ependymoma

J Siffert¹, J C Allen

¹Division of Pediatric Neurology, Department of Neurology, Beth Israel Medical Center, New York, N.Y., USA. jsiffert@bethisraelny.org

Pediatric Neurosurgery

|October 23, 1998

Summary

Ependymoma treatment offers long-term remission for half of patients. Chemotherapy shows limited benefit, especially in recurrent ependymoma cases, with ongoing research into novel therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Improvement in quality of life among Sri Lankan patients with haemorrhoids after invasive treatment: a longitudinal observational study.

BJS open·2021

Same author

Thermography in rheumatoid arthritis: a comparison with ultrasonography and clinical joint assessment.

Clinical radiology·2020

Same author

Accuracy of parent-reported ages and stages questionnaire in assessing the motor and language skills of preterm infants.

Journal of neonatal-perinatal medicine·2020

Same author

The Health Opportunity Index: Understanding the Input to Disparate Health Outcomes in Vulnerable and High-Risk Census Tracts.

International journal of environmental research and public health·2020

Same author

Determining competence in performing obstetric combined spinal-epidural procedures in junior anesthesiology residents: results from a cumulative sum analysis.

International journal of obstetric anesthesia·2020

Same author

Periprosthetic Fractures after Total Knee Arthroplasty: the Influence of Pre-Operative Mechanical Factors versus Intraoperative Factors.

Malaysian orthopaedic journal·2019

Area of Science:

Neuro-oncology
Pediatric oncology
Clinical trial analysis

Background:

Ependymoma treatment involves surgery and radiation, achieving remission in about 50% of newly diagnosed patients.
Chemotherapy has a limited role in ependymoma management, primarily used in infants to delay radiation.
The efficacy of chemotherapy in older children with newly diagnosed ependymoma is inconclusive, with more data available for recurrent disease.

Purpose of the Study:

To analyze clinical trials of single-agent and multiagent chemotherapy in recurrent ependymoma.
To discuss the role of chemotherapy in managing recurrent ependymoma in children.
To explore future directions in novel medical oncologic therapies for ependymoma.

Main Methods:

Review of principal institutional and cooperative group phase I, II, and III clinical trials.
Analysis of chemotherapy regimens (single-agent and multiagent) in recurrent ependymoma.
Discussion of existing literature and clinical experiences.

Main Results:

Chemotherapy has a limited role in ependymoma, particularly in recurrent disease.
Data on chemotherapy for recurrent ependymoma is primarily derived from clinical trials in children.
The use of chemotherapy in newly diagnosed older children has not shown conclusive benefits.

Conclusions:

Surgical resection and radiation therapy remain primary treatments for ependymoma.
Chemotherapy's role is limited, especially in recurrent ependymoma, necessitating further research.
Novel medical oncologic therapies are being investigated for future ependymoma treatment strategies.

Related Experiment Videos